NeoDynamics AB:企業の製品パイプライン分析

◆英語タイトル:NeoDynamics AB - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME449901PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NeoDynamics AB (NeoDynamics) is a medical technology company that develops medical solutions for the early detection and treatment of cancer. The company develops the NeoNavia biopsy system that helps to collect samples from breast lesions or axillary lymph nodes for diagnostic analysis of breast abnormalities. Its NeoNavia biopsy system is designed to manage challenges related to axillary lymph node biopsies such as injuring small or large blood vessels, injuring nerves, injuring the thoracic muscles and pneumothorax. The company offers medical solutions to clinicians and physicians. NeoDynamics is headquartered in Stockholm, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NeoDynamics AB
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
NeoDynamics AB Company Overview
NeoDynamics AB Company Snapshot
NeoDynamics AB Pipeline Products and Ongoing Clinical Trials Overview
NeoDynamics AB – Pipeline Analysis Overview
NeoDynamics AB – Key Facts
NeoDynamics AB – Major Products and Services
NeoDynamics AB Pipeline Products by Development Stage
NeoDynamics AB Ongoing Clinical Trials by Trial Status
NeoDynamics AB Pipeline Products Overview
Cytotest
Cytotest Product Overview
NeoNavia Biopsy System
NeoNavia Biopsy System Product Overview
NeoNavia Biopsy System Clinical Trial
NeoNavia duo
NeoNavia duo Product Overview
NeoNavia duo Clinical Trial
Preferential Radiofrequency Ablation (PRFA) Device
Preferential Radiofrequency Ablation (PRFA) Device Product Overview
NeoDynamics AB – Key Competitors
NeoDynamics AB – Key Employees
NeoDynamics AB – Locations And Subsidiaries
Head Office
Recent Developments
NeoDynamics AB, Recent Developments
Feb 05, 2020: NeoDynamics full-year report 2019
Feb 03, 2020: A clinical study performed at Karolinska Hospital with NeoDynamics’ new biopsy system, NeoNavia, has been accepted as an abstract by the Society for Breast Imaging (SBI) in the US.
Nov 27, 2019: NeoDynamics signs manufacturing agreement for NeoNavia
Nov 21, 2019: NeoDynamics third quarter jul-sep 2019
Oct 29, 2019: NeoDynamics receives regulatory approval for new Breast Cancer biopsy system
Sep 03, 2019: Redeye initiates coverage of NeoDynamics
Aug 28, 2019: NeoDynamics half-year report 2019
May 21, 2019: NeoDynamics – Quarterly report January-March 2019
Apr 26, 2019: NeoDynamics receives advance notice from U.S. Patent Office for a granted biopsy instrument patent
Apr 10, 2019: New breast biopsy device is evaluated at Karolinska University Hospital in Stockholm
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
NeoDynamics AB Pipeline Products and Ongoing Clinical Trials Overview
NeoDynamics AB Pipeline Products by Equipment Type
NeoDynamics AB Pipeline Products by Indication
NeoDynamics AB Ongoing Clinical Trials by Trial Status
NeoDynamics AB, Key Facts
NeoDynamics AB, Major Products and Services
NeoDynamics AB Number of Pipeline Products by Development Stage
NeoDynamics AB Pipeline Products Summary by Development Stage
NeoDynamics AB Ongoing Clinical Trials by Trial Status
NeoDynamics AB Ongoing Clinical Trials Summary
Cytotest - Product Status
Cytotest - Product Description
NeoNavia Biopsy System - Product Status
NeoNavia Biopsy System - Product Description
NeoNavia Biopsy System - Comparison Trial of Open-tip Pulsed Needle Biopsy and Conventional Core Biopsy in Axillary Lymph Nodes
NeoNavia Biopsy System - Percutaneous Ultrasound-Guided Biopsy Evaluated for Axillary Lymph Node Sampling Efficacy: PULSE
NeoNavia duo - Product Status
NeoNavia duo - Product Description
NeoNavia duo - Evaluation of NeoNavia Biopsy System in Breast Cancer Patients
Preferential Radiofrequency Ablation (PRFA) Device - Product Status
Preferential Radiofrequency Ablation (PRFA) Device - Product Description
NeoDynamics AB, Key Employees
Glossary

★海外企業調査レポート[NeoDynamics AB:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sanochemia Pharmazeutika AG (SAC)-医療機器分野:企業M&A・提携分析
    Summary Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures of innovative drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio i …
  • Nephros Inc (NEPH):企業の財務・戦略的SWOT分析
    Summary Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended …
  • CellaVision AB (CEVI):企業の財務・戦略的SWOT分析
    CellaVision AB (CEVI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Caixa Economica Federal
    Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nufarm Ltd (NUF):企業の財務・戦略的SWOT分析
    Nufarm Ltd (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Novelis Inc:企業の戦略・SWOT・財務分析
    Novelis Inc - Strategy, SWOT and Corporate Finance Report Summary Novelis Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • PetVivo Holdings Inc (PETV):企業の製品パイプライン分析2018
    Summary PetVivo Holdings Inc (PetVivo Holdings), formerly Technologies Scan Corp, is a biomedical device company. The company offers licensing and commercialization of medical devices and therapeutics to treat pets and animals suffering from arthritis and other afflictions. Its products include Kush …
  • Incanthera Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Incanthera Ltd (Incanthera) is a drug development and targeted cancer medicines company that discovers and develops novel treatments for solid tumours. The company's pipeline drug candidates include ICT01-2588, a vascular disrupting agent, based on the tumor-blasting technology; ICT03 – Es5, …
  • Exagen Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Exagen Diagnostics Inc (Exagen) is a medical device company that offers diagnostic tools. The company provides clinical tools for diagnosis, monitoring and prognosis of autoimmune connective tissue disease. Its products are used for therapeutic drug monitoring of hydroxychloroquine in whole …
  • Sapura Energy Bhd (SENERGY):石油・ガス:M&Aディール及び事業提携情報
    Summary Sapura Energy Bhd (Sapura) formerly known as SapuraKencana Petroleum Berhad is a global provider of integrated oil and gas services and solutions. It focuses on upstream business covering exploration, development, production, as well as decommissioning and abandonment stages. The company’s s …
  • Singapore Press Holdings Ltd (T39)
    Singapore Press Holdings Ltd (T39) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Elasmogen Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Elasmogen Ltd (Elasmogen), formerly Pacific Shelf 1760 Ltd is a biopharmaceutical company that discovers and develops sight-saving therapies for the treatment of inflammatory diseases of the eye and inflammatory conditions of the gut. The company develops soloMER that are small (11 kDa) and …
  • Fair Isaac Corp (FICO):企業の財務・戦略的SWOT分析
    Fair Isaac Corp (FICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Pancontinental Oil & Gas NL (PCL):企業の財務・戦略的SWOT分析
    Summary Pancontinental Oil & Gas NL (Pancontinental) is an oil and gas exploration and production company. The company carries out acquisition, exploration and development of conventional oil and gas properties. The company offers projects such as Namibia Walvis Basin EL 0037, Kenya Lamu Basin L6, T …
  • Discovery Inc (DISCA):企業の財務・戦略的SWOT分析
    Discovery Inc (DISCA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Exelon Corporation:企業の戦略・SWOT・財務情報
    Exelon Corporation - Strategy, SWOT and Corporate Finance Report Summary Exelon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hermes Europe GmbH:企業の戦略的SWOT分析
    Hermes Europe GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析
    Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Extendicare Inc (EXE):企業の財務・戦略的SWOT分析
    Summary Extendicare Inc (Extendicare), formerly Crownx Inc is a healthcare service provider that offers long-term care services. The center’s services include short stay care, convalescent care, home health care, group purchasing, assisted living, retirement living, workplace health and wellness, sk …
  • PetroQuest Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    PetroQuest Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary PetroQuest Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive inform …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆